Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of AA4500-treated subjects with Dupuytren's contracture
2008-007872-99Phase 3Completed
- Sponsor
- Auxilium UK Limited
- Start
- Nov 2009
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Auxilium UK Limited. Primary endpoints: Durability of response in previously improved joints, Progression or recurrence of Dupuytren's disease and 1 more. Started Nov 2009; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2008-007872-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007872-99.